[HTML][HTML] A phase 1, randomized, double-blinded, placebo-controlled and dose-escalation study to evaluate the safety and immunogenicity of the intranasal DelNS1 …
R Zhang, KH Chan, P Wang, R Zhou, HKC Yau… - Vaccines, 2023 - mdpi.com
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
[PDF][PDF] A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1 …
R Zhang, KH Chan, P Wang, R Zhou, HKC Yau… - 2023 - pdfs.semanticscholar.org
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
[HTML][HTML] A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal …
R Zhang, KH Chan, P Wang, R Zhou, HKC Yau… - Vaccines, 2023 - ncbi.nlm.nih.gov
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV …
R Zhang, C Kwok-Hung, P Wang, R Zhou… - Vaccines, 2023 - search.proquest.com
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV …
R Zhang, KH Chan, P Wang, R Zhou, HK Yau… - Vaccines, 2023 - europepmc.org
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV …
R Zhang, KH Chan, P Wang, R Zhou, HKC Yau… - …, 2023 - pubmed.ncbi.nlm.nih.gov
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV …
RQ Zhang, KH Chan, P Wang, RH Zhou, HKC Yau… - Vaccines, 2023 - hub.hku.hk
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal Delns1-nCoV …
RRQ Zhang, KH Chan, P Wang, R Zhou, HKC Yau… - papers.ssrn.com
Background: An intranasal vaccine, DelNS1-based RBD vaccines composed of H1N1
subtype (DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and …
subtype (DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and …
A phase 1, randomized, double-blinded, placebo-controlled and dose-escalation study to evaluate the safety and immunogenicity of the intranasal DelNS1-nCoV …
R Zhang, KH Chan, P Wang, R Zhou, HKC Yau… - 2023 - cabidigitallibrary.org
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV …
R Zhang, KH Chan, P Wang, R Zhou, HK Yau… - Vaccines, 2023 - europepmc.org
An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …
(DelNS1-nCoV-RBD LAIV) was developed to evaluate the safety and immunogenicity in …